[ASAP] Chemoproteomics-Enabled De Novo Proteolysis Targeting Chimera Discovery Platform Identifies a Metallothionein Degrader to Probe Its Role in Cancer 🔗 Access full article via Journal of the American Chemical SocietyShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
